Moderna
$190.01Change from previous close: +0.57%Absolute change: +$1.07
At a glance
- Revenue growth
- −39.93%
- 2025 vs 2024
- Net margin
- -145.2%
- 2024: -110.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -526 | -630 | 930 | -847 | -919 | -1,037 | 825 | -1,566 | -1,274 | -989 | 622 | -1,600 |
| Depreciation and amortization | 63.0 | 59.0 | 67.0 | 52.0 | 57.0 | 39.0 | 60.0 | 52.0 | 41.0 | 36.0 | 202 | 249 |
| Capital expenditure | -37.0 | -62.0 | -39.0 | -33.0 | -3.0 | -117 | -522 | -151 | -182 | -196 | -220 | -140 |
| Investing cash flow | 329 | -76.0 | -48.0 | 700 | 564 | 730 | -539 | 721 | 1,649 | 118 | -538 | 789 |
| Financing cash flow | 14.0 | 17.0 | 581 | -1.0 | 9.0 | 4.0 | -3.0 | 11.0 | 34.0 | 14.0 | -109 | -58.0 |
| Share repurchases | -2.0 | -2.0 | -1.0 | 0.0 | 0.0 | -1.0 | — | — | — | — | — | — |
| Debt issued | — | — | 600 | — | -2.0 | 2.0 | -4.0 | 3.0 | 1.0 | — | — | — |
| Debt repaid | -7.0 | — | -12.0 | -3.0 | -3.0 | — | -10.0 | — | 1.0 | -1.0 | -124 | -65.0 |
| Effect of exchange rates | -2.0 | 1.0 | 0.0 | 1.0 | 1.0 | — | -1.0 | 1.0 | — | — | — | — |
| Net change in cash | -185 | -688 | 1,463 | -147 | -345 | -303 | 282 | -833 | 409 | -857 | -25.0 | -869 |
| Free cash flow | -563 | -692 | 891 | -880 | -922 | -1,154 | 303 | -1,717 | -1,456 | -1,185 | 402 | -1,740 |
| Levered free cash flow | -345 | 352 | 1,261 | -969 | -665 | -955 | 604 | -1,849 | -998 | -845 | 354 | -864 |